4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0000904454-14-000773
10% owner gave up 2,683 shares (to pay taxes)
- 10% owner acquired 4,397 shares (option exercise)
- 10% owner acquired 46,309 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
DP VII ASSOCIATES LP · 10% owner
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-25 | Conversion : show line 1 in the form | +46,309 | 46,309 | D | ||
| 2014-11-25 | Exercise or conversion : show line 2 in the form | +1,570 | $8.54 | $13,408 | 47,879 | D |
| 2014-11-25 | Shares withheld for taxes : show line 3 in the form | −958 | $14.00 | $13,412 | 46,921 | D |
| 2014-11-25 | Exercise or conversion : show line 4 in the form | +2,827 | $8.54 | $24,143 | 49,748 | D |
| 2014-11-25 | Shares withheld for taxes : show line 5 in the form | −1,725 | $14.00 | $24,150 | 48,023 | D |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-25 | Conversion : show line 6 in the form Series A Preferred Stock | −12,578 | 0 | D |
| 2014-11-25 | Conversion : show line 7 in the form Series B Preferred Stock | −104,247 | 0 | D |
| 2014-11-25 | Conversion : show line 8 in the form Series B-2 Preferred Stock | −36,913 | 0 | D |
| 2014-11-25 | Conversion : show line 9 in the form Series C Preferred Stock | −102,282 | 0 | D |
| 2014-11-25 | Exercise or conversion : show line 10 in the form Series B-2 Preferred Stock Warrant (Right to Buy) | −1,570 | 0 | D |
| 2014-11-25 | Exercise or conversion : show line 11 in the form Series C Preferred Stock Warrant (Right to Buy) | −2,827 | 0 | D |
Loading xslF345X03/edgar.xml…